leisure time -WSS

leisure time

author：knowledge 2025-09-28 20:32:06 - browse：8924

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

hotspot

WSS

Making the case for fair compensation in clinical trials

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Fentanyl is making it harder to start addiction treatment

UnitedHealth argues against case alleging wrongful AI care denials

FDA poised to publish guidelines for clinical trial diversity

Bird flu surveillance in wastewater gets boost from consortium

Wikipedia

leisure time

focus

As demand for Covid shots wanes, Moderna seeks its next success

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Heart attack and stroke risk calculators need revising

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Fentanyl is making it harder to start addiction treatment

ChatGPT in medicine: STAT answers readers' burning questions

Study finds gene variants tied to breast cancer risk in Black women

Guidelines to prevent youth baseball injuries need more muscle

Why getting cancer drugs just got harder for rural patients

hotspot

AstraZeneca loses challenge to Medicare drug price negotiation

FogPharma raises $145 million in rare Series E round

Investigation reveals sickle cell patients pressured into sterilizations

Eyeing GLP

FDA poised to publish guidelines for clinical trial diversity

Congress gives doctors Medicare pay bump

leisure time

explore

hotspot

entertainment